2014, Número 2
<< Anterior Siguiente >>
Rev Cent Dermatol Pascua 2014; 23 (2)
Eccema herpético. Presentación de un caso típico asociado con dermatitis atópica y breve revisión de actualidades sobre su fisiopatología
López CLD, Gómez MGA
Idioma: Español
Referencias bibliográficas: 21
Paginas: 59-62
Archivo PDF: 222.72 Kb.
RESUMEN
El eccema herpético, también conocido como erupción variceliforme de Kaposi, es una expresión diseminada de la infección por el virus del herpes simple. Suele presentarse sobre una piel con una dermatosis previa, con mayor frecuencia dermatitis atópica. Comunicamos el caso de un paciente del sexo masculino, de 15 años de edad, con eccema herpético asociado con dermatitis atópica con buena respuesta a tratamiento antiviral y hacemos una revisión sobre las actualidades fisiopatológicas del tema.
REFERENCIAS (EN ESTE ARTÍCULO)
Marques A, Straus SE. Herpes simplex. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ. Fitzpatrick’s dermatology in general medicine. 7th Ed. New York; McGraw-Hill, 2008, pp. 1873-1883.
Mir-Bonafé JM, Román-Curto C, Santos-Briz A, Palacios-Álvarez I, Santos-Durán JC, Fernández-López E. Eczema herpeticum with herpetic folliculitis after bone marrow transplant under prophylactic acyclovir: are patients with underlying dermatologic disorders at higher risk? Transpl Infect Dis. 2013; 15: 75-80.
Gupta M, Huang V, Linette G, Cornelius L. Unusual complication of vemurafenib treatment of metastatic melanoma: exacerbation of acantholytic dyskeratosis complicated by Kaposi varicelliform eruption. Arch Dermatol. 2012; 148: 966-968.
Lübbe J, Pournaras CC, Saurat JH. Eczema herpeticum during treatment of atopic dermatitis with 0.1% tacrolimus ointment. Dermatology. 2000; 201: 249-251.
Segura S, Romero D, Carrera C, Iranzo P, Estrach T. Eczema herpeticum during treatment of atopic dermatitis with 1% pimecrolimus cream. Acta Derm Venereol. 2005; 85: 524-525.
Osawa K, Etoh T, Ariyoshi N, Ishii I, Ohtani M, Kariya S, Uchino K, Kitada M. Relationship between Kaposi’s variceliform eruption in Japanese patients with atopic dermatitis treated with tacrolimus ointment and genetic polymorphisms in the IL-18 gene promoter region. J Dermatol. 2007; 34: 531-536.
Kimata H. Kaposi’s varicelliform eruption associated with the use of tacrolimus ointment in two neonates. Indian J Dermatol Venereol Leprol. 2008; 74: 262-263.
Marín E, Eng A, Velázquez E. Erupción variceliforme de Kaposi, presentación de un caso. Rev Cent Dermatol Pascua. 2005; 14: 31-34.
Leung D. Why is eczema herpeticum unexpectedly rare? Antiviral Res. 2013; 98: 153-157.
Gao PS, Leung DY, Rafaels NM, Boguniewicz M, Hand T, Gao L et al. Genetic variants in interferon regulatory factor 2 (IRF2) are associated with atopic dermatitis and eczema herpeticum. J Invest Dermatol. 2012; 132: 650-657.
Beck LA, Boguniewicz M, Hata T, Schneider LC, Hanifin J, Gallo R et al. Phenotype of atopic dermatitis subjects with a history of eczema herpeticum. J Allergy Clin Immunol. 2009; 124: 260-269.
Haapakoski R, Karisola P, Fyhrquist N, Savinko T, Lehtimäki S, Wolff H et al. Toll-like receptor activation during cutaneous allergen sensitization blocks development of asthma through IFN-gamma-dependent mechanisms. J Invest Dermatol. 2013; 133: 964-972.
Kuo IH, Carpenter-Mendini A, Yoshida T, McGirt LY, Ivanov AI, Barnes KC et al. Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair. J Invest Dermatol. 2013; 133: 988-998.
Gao PS, Rafaels NM, Hand T et al. Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum. J Allergy Clin Immunol. 2009; 124: 507-513.
Benedetto A, Slifka MK, Rafaels NM, Kuo IH, Georas SN, Boguniewicz M et al. Reductions in Claudin-1 may enhance susceptibility to HSV-1 infections inatopic dermatitis. J Allergy Clin Immunol. 2011; 128: 242-246.
Bin L, Kim BE, Brauweiler A, Goleva E, Streib J, Ji Y et al. Staphylococcus aureus α-toxin modulates skin host response to viral infection. J Allergy Clin Immunol. 2012; 130: 683-691.
Lübbe J, Pournaras CC, Saurat JH. Eczema herpeticum during treatment of atopic dermatitis with 0.1% tacrolimus ointment. Dermatology. 2000; 201: 249-251.
Ambo M. Relapsing Kaposi’s varicelliform eruption and herpes simplex following facial tacrolimus treatment for atopic dermatitis. Acta Derm Venereol. 2002; 82: 224-225.
Segura S, Romero D, Carrera C, Iranzo P, Estrach T. Eczema herpeticum during treatment of atopic dermatitis with 1% pimecrolimus cream. Acta Derm Venereol. 2005; 85: 524-525.
Kimata H. Kaposi’s varicelliform eruption associated with the use of tacrolimus ointment in two neonates. Indian J Dermatol Venereol Leprol. 2008; 74: 262-263.
Kim M, Jung M, Hong SP, Jeon H, Kim MJ, Cho MY et al. Topical calcineurin inhibitors compromise stratum corneum integrity, epidermal permeability and antimicrobial barrier function. Exp Dermatol. 2010; 19: 501-510.